The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancersNOUS-209 is an off-the-shelf cancer immunotherapy designed to induce T ...

Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...

“Climate resilience will be one of the major sustainability topics in 2026, grabbing the attention of everyone from investors ...

Dr. Ash Kapoor, founder of Levitas One, speaks about how cutting-edge longevity science meets ancient wisdom to help us live ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

The final run -- a strafing pass with the jet's 20-mm cannon -- vibrated through the airframe. It was disorienting, visceral, ...

As we age, we don't recover from injury or illness like we did when we were young. But new research from UCSF has found gene ...